PortView
VanEck Biotech (BBH) ETF Holdings & Analysis
ETFOther
What BBH does
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Amgen Inc | 15.57% | |
| Gilead Sciences Inc | 12.74% | |
| Vertex Pharmaceuticals Inc | 8.58% | |
| Regeneron Pharmaceuticals Inc | 6.84% | |
| Moderna Inc | 5.80% | |
| Natera Inc | 5.02% | |
| Iqvia Holdings Inc | 5.01% | |
| Revolution Medicines Inc | 4.98% | |
| Argenx Se | 4.75% | |
| Illumina Inc | 3.31% |
Sector allocation
| Healthcare | 100.00% |
Geographic allocation
| United States | 87.71% |
| Netherlands | 5.73% |
| Switzerland | 3.11% |
| Germany | 1.83% |
| Ireland | 1.60% |
| Other | 0.03% |
PortView Portfolio Insights
PortView analyzes how BBH fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BBH in PortView →Related securities
Related stocks
Frequently asked questions
- What does BBH track?
- BBH is the VanEck Biotech ETF, a Other ETF.
- What is the expense ratio of BBH?
- Expense ratio data for BBH is shown on the page when available from our data provider.
- What are the largest holdings in BBH?
- Top holdings include AMGN, GILD, VRTX, REGN, MRNA.
- How can PortView analyze BBH overlap with other ETFs?
- PortView computes the holdings overlap between BBH and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.